Copeland Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-12,584
| Closed | -$456K | – | 140 |
|
|
2016
Q4 | $456K | Sell |
12,584
-7,474
| -37% | -$271K | 0.03% | 128 |
|
|
2016
Q3 | $923K | Sell |
20,058
-42,326
| -68% | -$1.95M | 0.06% | 125 |
|
|
2016
Q2 | $3.13M | Buy |
62,384
+2,490
| +4% | +$125K | 0.22% | 102 |
|
|
2016
Q1 | $3.21M | Buy |
59,894
+19,450
| +48% | +$1.04M | 0.22% | 102 |
|
|
2015
Q4 | $2.65M | Sell |
40,444
-334,734
| -89% | -$22M | 0.15% | 113 |
|
|
2015
Q3 | $21.2M | Buy |
375,178
+104,955
| +39% | +$5.93M | 1.3% | 27 |
|
|
2015
Q2 | $16M | Buy |
270,223
+12,534
| +5% | +$741K | 0.82% | 53 |
|
|
2015
Q1 | $16.1M | Sell |
257,689
-1,588
| -0.6% | -$98.9K | 1.07% | 38 |
|
|
2014
Q4 | $14.9M | Buy |
259,277
+232,547
| +870% | +$13.4M | 1.08% | 45 |
|
|
2014
Q3 | $1.44M | Buy |
26,730
+2,601
| +11% | +$140K | 0.15% | 63 |
|
|
2014
Q2 | $1.27M | Buy |
24,129
+7,259
| +43% | +$381K | 0.14% | 66 |
|
|
2014
Q1 | $891K | Buy |
16,870
+4,537
| +37% | +$240K | 0.11% | 78 |
|
|
2013
Q4 | $494K | Buy |
+12,333
| New | +$494K | 0.06% | 90 |
|